SCHEMBL6723723

SCHEMBL6723723

CCOC(=O)C(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)NC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 10/20 0.58
THRA P10827 7/20 0.58
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
PPARG P37231 5/20 0.58
LMNA P02545 5/20 0.58
USP2 O75604 4/20 0.58
HSD17B10 Q99714 3/20 0.58
TTR P02766 2/20 0.58
ADORA3 P0DMS8 2/20 0.58
PDE4D Q08499 2/20 0.58
RXRA P19793 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
NR3C1 P04150 1/20 0.58
CYP1A2 P05177 1/20 0.58
HTR1A P08908 1/20 0.58
CYP2C9 P11712 1/20 0.58
TBXA2R P21731 1/20 0.58
NTSR1 P30989 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723726 1.00 THRB (0.58) THRBTHRAMEN1KMT2APPARG
SCHEMBL10878152 0.91 THRB (0.60) THRBTHRAMEN1KMT2APPARG
SCHEMBL9056612 0.90 TACR1 (0.49) THRBTHRAMEN1KMT2APPARG
SCHEMBL10790967 0.90 TACR1 (0.49) THRBTHRAMEN1KMT2APPARG
SCHEMBL28680811 0.89 PCNA (0.67) THRBTHRAMEN1KMT2APPARG
SCHEMBL28680813 0.89 PCNA (0.67) THRBTHRAMEN1KMT2APPARG
SCHEMBL1525929 0.88 THRB (0.57) THRBTHRAMEN1KMT2APPARG
SCHEMBL468892 0.87 THRB (0.69) THRBTHRAMEN1KMT2APPARG
SCHEMBL468893 0.87 THRB (0.69) THRBTHRAMEN1KMT2APPARG
SCHEMBL8731461 0.87 THRB (0.51) THRBTHRAMEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116715597-B Production process of levothyroxine sodium 湖北潜龙药业有限公司 2025-03-07 CN disclosed
CN-116715597-A Production process of levothyroxine sodium 湖北潜龙药业有限公司 2023-09-08 CN disclosed
CN-102199103-B Improved method for synthesizing L-thyroxine sodium CHANGZHOU INST ENG TECH 2013-12-25 CN disclosed
CN-102199103-A Improved method for synthesizing L-thyroxine sodium CHANGZHOU INST ENG TECH 2011-09-28 CN disclosed
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 US disclosed
WO-2001036351-A2 PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS CORVAS INTERNATIONAL, INC. (US) 2001-05-25 WO disclosed
US-4670395-A Enantioselective hydrolysis of N-acylamino acid esters using a combined enzyme system THE STANDARD OIL COMPANY (US) 1987-06-02 US disclosed